WSO Elite Modeling Package

  • 6 courses to mastery: Excel, Financial Statement, LBO, M&A, Valuation and DCF
  • Elite instructors from top BB investment banks and private equity megafunds
  • Includes Company DB + Video Library Access (1 year)

Comments (60)

Learn More

300+ video lessons across 6 modeling courses taught by elite practitioners at the top investment banks and private equity funds -- Excel Modeling -- Financial Statement Modeling -- M&A Modeling -- LBO Modeling -- DCF and Valuation Modeling -- ALL INCLUDED + 2 Huge Bonuses.

Learn more
Jul 11, 2021 - 11:17am

Ive said this before, but things are never as clear as the tier lists that get posted on this board. On the RX side, Gugg has won some really good mandates (AAL, MNK, WPG all company side). Their fees have been pretty impressive too. At least for the time being, they also pay more (although not sure how long that will last). I know people in my class who turned down offers at 'better' practices (at least thats what people here would tell you) for gugg too. All that combined, Gugg i think is a pretty solid practice thats doing well in the space (I can't speak as much to their exit opps though). Practically speaking, if I were recruiting for SA, I wouldn't hesitate to apply and accept an offer, and if I were lucky enough to have a couple of options, I'd worry about how they stacked up then.

  • Prospect in HF - Other
Jul 12, 2021 - 8:01pm

Doing some esoteric structured finance at Gugg sounds pretty sick, they sound like the type of firm to create synthetic CDOs for OnlyFans cash flows.

  • Prospect in IB-M&A
Jul 11, 2021 - 10:56am

Curious how people view their RX team now that they've gone on some good stuff after getting more senior hires. And I understand the "not an EB" term, but the analysts exit pretty well still which is an important thing to consider

  • Associate 1 in IB - Cov
Jul 11, 2021 - 9:43pm

Exits to Cerberus, Centerbridge, Searchlight, Owl Creek, Veritas Capital, Balyasny in the past 2 years. Pretty good considering the class sizes

  • Intern in IB - CB
Jul 13, 2021 - 8:31pm

At my top target, everyone reneges on Greenhill lol. The only ones who sign are those who couldn't get better offers even at mid-tier BBs

  • Associate 1 in IB-M&A
Jul 14, 2021 - 1:00am

Was a good shop a decade+ back, but been on steep downhill and failed to gain momentum/ M&A market share post-2008 while Evercore has been/ already is rising to/at the top in M&A playing field, PJT/ Lazard maintaining their status quo in terms of reps, and Centerview growing in select sectors (HC/CR). Unfortunately Greenhill's behind other EBs like Moelis as well. 

  • Analyst 1 in IB-M&A
Jul 14, 2021 - 7:16am

When do people think Greenhill started to fall off? I feel like when I was recruiting (2 years ago) people still had it firmly in the EB camp- is it just that they haven't capitalized off the post-COVID boom like every other bank has? Clearly they've been slipping for a while but seems like only recently things started to really change with how people viewed it

Jul 14, 2021 - 9:36am

I think it might have to do with the founder Bob Greenhill stepping down and away from the business maybe. I think the new CEO Scott Bok is good and all but it's like not "his" company so much. Prob hard for him to be motivated to grow the business/brand when he is only really collecting a paycheck. The other EBs are kinda like the founder's babies. Hey, even GS is kinda like David Solomon's baby at this point with how they set it up for him to have so much influence and association with the future of the bank. Same with Jamie JPM. I could be very wrong but to me it seems like Greenhill is more of a limited life sole proprietorship. When Bob went / goes away I'm not sure if the bank really survives him too much as it looks like it is happening. I may be wrong and things can change. Just seems like one of the challenges of starting a long-term business is founder succession. Maybe GHL has not been able to or wanted to focus too much on that. Idk

Jul 15, 2021 - 12:13am

Eius recusandae et ut totam nesciunt. Id necessitatibus ea aut. Et explicabo illum qui neque est fugiat deleniti.

Rerum odit ratione hic neque enim. Vel consequatur eius ex cum ex enim. Aperiam culpa quaerat ipsam architecto totam maxime eaque. Magnam est nihil eos fuga non assumenda voluptates reiciendis. Sit mollitia est et quam itaque officiis nihil. Consequatur est nemo reiciendis et vel sint nihil. Et ipsum sunt in perferendis optio perspiciatis.

  • Analyst 1 in IB-M&A
Jul 17, 2021 - 8:25am

Nisi eaque hic illo autem aperiam est et. Voluptatibus ut et fugit omnis quo nostrum quia.

Aut ducimus corporis id aut rerum. Excepturi quis ipsum voluptas voluptatem.

Omnis suscipit veniam sed consequatur odit rerum. Eaque ut enim ipsam excepturi hic perferendis et cupiditate. Illum veniam consequatur et. Tempora reprehenderit repellendus sunt totam sit qui. Perferendis aut quidem aut nemo exercitationem autem laudantium.

Start Discussion

Total Avg Compensation

September 2021 Investment Banking

  • Director/MD (10) $853
  • Vice President (39) $363
  • Associates (220) $232
  • 2nd Year Analyst (135) $154
  • 3rd+ Year Analyst (30) $147
  • Intern/Summer Associate (103) $143
  • 1st Year Analyst (487) $135
  • Intern/Summer Analyst (377) $82